The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC):

The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC):


Published

November 12, 2018

Created by

CMEducation Resources symposium

Related Presenters

Omid Hamid, MD

Omid Hamid, MD

Chief, Translational Research/Immuno-Oncology
Director, Experimental Therapeutics Cedars Sinai Foundation